Based on clinical evidence to date, including newly released findings in 11 patients at one year post-procedure, Fractyl Health believes that by resurfacing and reversing the pathology of the duodenal lining, its Revita system has the potential to become the first disease-modifying therapy that targets a root cause of obesity and type 2 diabetes.
Fractyl Health, Inc. released clinical results on 8 August indicating that its Revita outpatient endoscopic procedure could be a weight maintenance and blood sugar solution in “one of the hardest to treat populations.”
Founded in 2010, Burlington, MA-based Fractyl is pioneering new approaches to treat metabolic diseases, including obesity and type 2 diabetes...
A recent approval from the US FDA allowing Boston Scientific to broaden its labeling for its pulse field ablation system means more patients with one type of AFib will have access to a promising new treatment.
The Milner Institute, the on-campus hub for start-up acceleration at Cambridge University, hosted its annual Pitch Day on July 1. Start-ups Panakeia, PathwayBio and Sentinal4D presented diagnostic technologies.
Broad participation by EU member states in a new pilot to test a unified procedure for evaluating applications for combined drug and IVD studies shows they recognize its value, says Monique Al, vice-chair of the Clinical Trials Coordination Group.
Dexcom’s CEO Kevin Sayer discusses this fall’s planned launch of the 15-day G7 CGM, downplays Abbott’s dual-sensor while focusing on development of multi-analyte G8, making OTC Stelo app more “consumerish” for Europeans, and more.
The Milner Institute, the on-campus hub for start-up acceleration at Cambridge University, hosted its annual Pitch Day on July 1. Start-ups Panakeia, PathwayBio and Sentinal4D presented diagnostic technologies.
To succeed in medtech, investors must focus on patient outcomes. Gilde Healthcare says involving patients boosts product effectiveness, access and market success — making it a smart strategy in today’s strained healthcare systems.
While European sustainability directives CSDDD and CSRD are still in the process of adoption, environmental group Swedwatch claims the EU's procurement framework is devoid of accountability.
